Study identifies ECM1 protein as key regulator of liver regeneration after injury
Researchers found that extracellular matrix protein 1 (ECM1) acts as a physiological brake on hepatocyte growth factor (HGF), and its temporary suppression is necessary for liver regeneration following partial hepatectomy. ECM1 directly inhibits HGF signaling by binding to its active form, and preventing ECM1 downregulation delays liver mass recovery. This discovery could inform therapeutic approaches to enhance tissue repair and regeneration.
A new study published on bioRxiv identifies ECM1 as a critical gatekeeper protein that regulates liver regeneration by suppressing hepatocyte growth factor (HGF) activity. In experiments using 70% partial hepatectomy models, researchers observed that active HGF levels rapidly increased while ECM1 levels sharply declined, and blocking this ECM1 reduction delayed liver mass recovery. The mechanism involves ECM1 directly binding to active HGF through a specific amino acid residue (R392), which suppresses the c-MET-ERK-MYC signaling pathway essential for hepatocyte proliferation. The findings were validated through transcriptomic analyses, computational modeling, and clinical observations showing that proliferating hepatocytes localize to ECM1-negative regions in patient samples. These results suggest ECM1 functions as a transient inhibitor whose downregulation is necessary to permit HGF-driven tissue repair.
What's missing
The study's own limitations and open questions are not detailed in the abstract provided, such as whether findings in animal models translate to human therapeutic contexts, the timeline for ECM1 re-expression post-regeneration, or potential off-target effects of ECM1 manipulation in clinical applications.
What different sources said
- bioRxivCenter
Transient suppression of the ECM1 gatekeeper is essential for HGF/c-MET-driven liver regeneration
Related
Study Shows Statins Reduce Coenzyme Q in Brain Cells, Impairing Mitochondrial Function
A laboratory study found that statin drugs decrease coenzyme Q levels in astrocytes (brain support cells) by 30-40%, reducing their mitochondrial energy production and increasing oxidative stress. Astrocytes are critical for maintaining brain health and protecting neurons from damage. The findings suggest CoQ10 supplementation may help counteract these effects, though human clinical evidence remains limited.
Study reveals zebrafish larvae exhibit slowly fluctuating directional swim biases driven by internal dynamics
Researchers found that 5-day-old zebrafish larvae display changing directional swim preferences over many hours even in stable environments, contrary to classical models assuming constant individual biases. Computational analysis suggests these fluctuations arise from a non-stationary Markovian process with two independent internal input streams modulating swim direction repetition. The findings suggest animals possess intrinsic mechanisms for generating behavioral variability independent of external stimuli, with implications for understanding how internal states shape adaptive behavior.
Two Small Molecules Show Promise as Broad-Spectrum Coronavirus Inhibitors in Laboratory Study
Researchers found that sennoside A and ceftazidime, two small molecules, can inhibit RNA binding in the nucleocapsid proteins of SARS-CoV-2, SARS-CoV, and MERS-CoV in laboratory experiments. The nucleocapsid protein is highly conserved across coronaviruses and essential for viral replication, making it a potential drug target. The findings suggest these compounds could form the basis for pan-coronavirus antiviral therapies, though further development and clinical testing would be needed.